Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Propionibacterium Infections : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Multimedia
References

Related Articles
Actinomycosis

Behcet Disease

Cryptococcosis




Patient Education
Click here for patient education.



Author: Sajeev Handa, MB, BCh, BAO, LRCSI, LRCPI, Director, Division of Hospitalist Medicine, Department of Medicine, Rhode Island Hospital

Sajeev Handa is a member of the following medical societies: Infectious Diseases Society of America and Society of Hospital Medicine

Editors: Douglas A Drevets, MD, Assistant Professor, Department of Medicine, Section of Infectious Disease, Oklahoma University Health Sciences Center; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Aaron Glatt, MD, Professor of Clinical Medicine, New York Medical College; Chief Medical Officer, Departments of Medicine and Infectious Diseases, New Island Hospital; Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital; Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Author and Editor Disclosure

Synonyms and related keywords: Propionibacterium acnes, P acnes, Propionibacterium granulosum, P granulosum, Propionibacterium avidum, P avidum, Propionibacterium propionicus, P propionicus pustular acne, acne vulgaris, cystic acne, nodular acne, acneiform drug eruptions

Background

Propionibacterium species are inhabitants of the skin and usually are nonpathogenic. As a result, they are common contaminants of blood and body fluid cultures. These species are slow-growing, nonsporulating, gram-positive anaerobic bacilli.

Propionibacterium species belong to the genera of Coryneforms and are the best studied because of their association with acne vulgaris. However, a number of other infections may be caused by Propionibacterium species, and these are described briefly in this article.

Propionibacterium acnes is found briefly on the skin of neonates, but true colonization begins during the 1-3 years prior to sexual maturity when numbers rise from fewer than 10/cm2 to about 106/cm2, chiefly on the face and upper thorax. In the lipid-rich microenvironment of the hair follicle, P acnes produces inflammatory mediators that result in papules, pustules, and later, nodulocystic lesions that are typical of inflammatory acne.

Propionibacterium granulosum is found in the same areas but at numbers about one hundredth of those of P acnes.

Both P acnes and P granulosum may be isolated from the gastrointestinal tract.

Propionibacterium avidum is found in the axilla, rather than on exposed areas, and increases in numbers at puberty.

Propionibacterium propionicus has been implicated as a less common causative agent of a disease process similar to actinomycosis. The most common cause of actinomycosis is Actinomyces israeli.

Frequency

United States

Acne vulgaris is sufficiently common that it may be considered physiologic.

Race

Acne appears to be a familial condition and is less common in Japanese people than in the white American population.

Sex

In girls, acne may precede menarche by more than 1 year. The greatest number of cases is observed during the middle-to-late teenage period, and incidence decreases subsequently. Males are affected more frequently than females are, and males tend to have more severe involvement.

Age

Acne vulgaris is a self-limited disease involving the sebaceous follicles observed primarily in adolescents. Occasionally, it is present at birth, and mild cases may be observed in the neonatal period. During puberty, acne typically becomes a common problem. The condition often is an early manifestation of puberty. In very young patients, the predominant lesions are comedones, and inflammatory lesions are rare.



History

  • Acne vulgaris
    • Propionibacterium acnes plays an important role in the pathogenesis of inflammatory acne–producing producing proinflammatory mediators, including lipases, neuraminidases, phosphatases, and proteases.
    • Acne usually affects the face and, to a lesser degree, the back, chest, and shoulders. On the trunk, lesions tend to be near the midline.
    • The 4 major pathophysiologic features of acne are the following:
      • Hyperkeratinization
      • Sebum production
      • Bacterial proliferation
      • Inflammation
    • Lesions can be described in 3 categories
      • Noninflammatory: Comedones are either open (black heads) or closed (whiteheads). The open comedo appears as a flat or slightly raised lesion with a central dark-colored follicular impaction of keratin and lipid. The closed comedo is a pale, slightly elevated, small papule without a visible orifice and is a potential precursor for the larger inflammatory lesions.
      • Inflammatory: Inflammatory lesions vary from small papules with an inflammatory areola to pustules (papulopustular) to large, tender, fluctuant nodules (nodular).
      • Scars: These appear as punched out pits of varying size and may have multiple openings.
    • Exacerbations of acne vulgaris may follow the ingestion of several drugs, such as iodides, bromides, glucocorticoids, and lithium, as well as the application of oil-containing compounds.
  • Other infections
  • Propionibacterium species have been identified rarely as causes of brain abscess, subdural empyema, dental infections, endocarditis, continuous ambulatory peritoneal dialysis (CAPD), conjunctivitis associated with contact lenses, and peritonitis.
  • P acnes has been identified as a frequently recovered cause of anaerobic arthritis in association with prosthetic joints and, rarely, has been implicated in cases of osteomyelitis , as well as prosthetic vascular graft infections. Cardiovascular device–related infections secondary to P acnes typically presents in a subtle fashion: low grade fever, weight loss, malaise, and myalgias.
  • P acnes has been isolated from an affected joint in rare cases of rheumatoid arthritis or chronic juvenile arthritis, presumably as a result of bacterial inoculation, usually during infiltration (injection).
  • P acnes also has been implicated in certain spondyloarthropathies associated with florid acne vulgaris, in which it was isolated from bone foci and from the joints.
  • P acnes has been reported as a cause of vision-threatening infectious keratitis when the cornea is compromised.
  • P granulosum has been isolated as a cause, albeit rarely, of endocarditis.



Actinomycosis
Behcet Disease
Cryptococcosis

Other Problems to be Considered

Acne vulgaris: Comedones are not unique to acne. Senile comedones are common and are observed particularly in the periorbital area of elderly persons, and comedones may be present as a result of radiation therapy.

Acnelike lesions may be observed in patients with Behçet disease and in immunocompromised hosts. Disseminated cryptococcosis may present as acneiform eruption.

Other diseases of the sebaceous cysts include atheromas, keratin cysts, and the development of pilar cysts.



Lab Studies

  • Acne vulgaris: Although many laboratory studies have been performed, the findings have not been significant in general. Androgen levels may be appropriate in select cases.
  • Other infections: In some high-risk patients, Propionibacterium species are capable of inducing significant infections, and efforts should be made to obtain specimens free of contamination by the normal flora of the mucous membranes and skin, where they reside. In addition, strict anaerobic technique should be followed in order to ensure isolation in suspected cases of Propionibacterium species infection.
  • In cases of P acnes causing infectious keratitis, isolates are culture positive on thioglycolate broth. None became positive before 7 days of growth, and the recommendation is to monitor the culture for at least 10 days to ensure isolation of this fastidious organism.

Imaging Studies

  • In cardiovascular device–related infections, P acnes can be difficult to recover in cultures of clinical specimens unless anaerobic cultures are obtained and held for extended periods. Computed tomography (CT) scans, ultrasonography, and magnetic resonance imaging (MRI) are useful in demonstrating fluid collection around a device, which can suggest infection. Percutaneous aspirate of the fluid with ultrasound or CT guidance may confirm device infection. Transesophageal echocardiography is required in order to visualize a vegetation in prosthetic valve endocarditis.



Medical Care

  • Acne vulgaris: Topical and oral agents act at various stages in the evolution of an acne lesion and may be used alone or in combination to enhance efficacy. Most cases are controlled with combinations of vitamin A acid, benzoyl peroxide, drying and peeling agents, and antibiotics. Topical agents should be applied to the entire affected area to treat existing lesions and to prevent the development of new ones. Potent topical steroid creams produce no short-term improvement in patients with moderate acne. Future treatments under study involve the potential use of laser therapy.
  • Other infections: Determination of the clinical significance of an isolate of Propionibacterium species must be made with caution because this will influence the need to direct therapy against that isolate.

Surgical Care

  • Acne vulgaris: Surgical care involves the manual removal of comedones and the drainage of pustules and cysts. When performed correctly, acne surgery speeds resolution and rapidly enhances cosmetic appearance. Scar revision by means of dermabrasion, excision, and gelatin matrix collagen implantation is performed in patients who are self-conscious about the pitted and craterlike scars that remain.

Consultations

  • Acne vulgaris: Referral to a dermatologist may be appropriate for patients who do not respond to conventional treatment.
  • Other infections: Isolation of Propionibacterium species in the settings described above may require the assistance of an infectious diseases specialist for interpretation.

Diet

In cases of acne vulgaris, no evidence supports the elimination of various foods such as sweets, chocolate, milk, and fatty foods. However, patients will indicate that they notice flares after the consumption of certain foods, such as chocolate. In these scenarios, eliminating the implicated food item would be reasonable if the patient feels that it is aggravating the condition.



The following information pertains to the treatment of acne vulgaris primarily.

For other infections caused by Propionibacterium species, antibiotics used for the treatment of anaerobic infections usually suffice. These include the penicillins, carbapenems, and clindamycin. In addition, vancomycin and teicoplanin have been used. Some of these antibiotics are discussed after the treatment of acne vulgaris.

Drug Category: Keratolytics

These agents cause cornified epithelium to swell, soften, macerate, and then desquamate. Retinoids are now classified into 3 generations. The first comprises topical tretinoin and systemic isotretinoin. The second generation retinoids are used to treat psoriasis. The third-generation retinoids include adapalene and tazarotene, which are topical agents.

Drug NameTretinoin (Retin-A, Avita)
DescriptionInhibits microcomedo formation and eliminates lesions present. Makes keratinocytes in sebaceous follicles less adherent and easier to remove. Available as 0.025%, 0.05%, and 0.1% creams. Available also as 0.01% and 0.025% gels.
Adult DoseBegin with lowest tretinoin formulation and increase as tolerated; apply hs or qod; reduce frequency of application if irritation develops
Pediatric Dose<12 years: Not established
>12 years: Administer as in adults
ContraindicationsDocumented hypersensitivity
InteractionsToxicity increases with coadministration of benzoyl peroxide, salicylic acid, and resorcinol; avoid topical sulfur, resorcinol, salicylic acid, other keratolytics, abrasives, astringents, spices, and lime
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsPhotosensitivity may occur with excessive sunlight exposure; caution in eczema; not to be applied to mucous membranes, mouth, and angles of nose

Drug NameBenzoyl peroxide (Benzac, Benoxyl)
DescriptionFree-radical oxygen is released upon administration and oxidizes bacterial proteins in sebaceous follicles, decreasing the quantity of irritating free fatty acids and of anaerobic bacteria. It also has keratolytic and comedolytic effects. This agent is most effective for inflammatory acne. It is available OTC and by prescription.
Adult DoseApply sparingly qd; gradually increase to bid/tid prn; reduce dose, frequency, or concentration if excessive dryness or peeling occurs
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsPotentiates adverse effects of tretinoin
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsAvoid contact with lips, eyelids, mucous membranes, and eyes; for external use only; discontinue if swelling, burning, or excessive dryness occurs

Drug NameAzelaic acid (Azelex, Finevin)
DescriptionHas been shown to help normalize keratinization and to reduce proliferation of P acnes and has proven to be effective against both noninflammatory and inflammatory lesions. This medication may decrease microcomedo formation in acne vulgaris and may have a bleaching effect on skin. May also have antimicrobial effect. Efficacy may be enhanced when used in combination with other topical medications (eg, benzoyl peroxide, clindamycin, tretinoin). Hands should be washed following application. Duration of treatment can vary from person to person and varies depending on severity. Improvement occurs in the majority of patients with inflammatory lesions within 4 wk.
Adult DoseWash area and apply sparingly bid; duration of use can vary from person to person and depends on severity of acne
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsAvoid contact with eyes; discontinue use if severe irritation develops; adverse reactions generally are mild and transient; most common adverse reactions (occurring in approximately 1-5% of patients) are pruritus, burning, stinging, and tingling

Drug NameTazarotene (Tazorac, Avage)
DescriptionRetinoid prodrug whose active metabolite modulates differentiation and proliferation of epithelial tissue; may also have anti-inflammatory and immunomodulatory properties. This agent is strictly contraindicated in pregnancy.
Adult DoseApply thin film (ie, 2 mg/cm2) hs to clean, dry skin where acne appears
Pediatric DoseChildren: Not established
Adolescents: Apply as in adults
ContraindicationsDocumented hypersensitivity
InteractionsDo not use concomitantly with dermatologic drugs or cosmetics that have a strong drying effect on the skin (eg, salicylic acid, benzoyl peroxide, astringents)
PregnancyX - Contraindicated in pregnancy
PrecautionsMay cause burning or stinging; discontinue upon excessive irritation; rinse thoroughly upon contact with eyes, eyelids, or mouth; may cause severe irritation in eczematous skin; photosensitivity may occur

Drug Category: Antibiotics

These agents are useful in papular, pustular, and cystic acne and must be taken for weeks to be effective. They are typically used for many weeks or months to achieve maximum benefit.

Long-term antibiotics may be required and necessitate monitoring for adverse drug events. Females should be warned about the development of vaginitis secondary to Candida albicans.

Topical antibiotics are useful in mild pustular and comedone acne. These preparations include clindamycin, erythromycin, and Benzamycin (erythromycin 3%-benzoyl peroxide 5% gel).

Drug NameErythromycin (E.E.S., E-Mycin, Eryc)
DescriptionInhibits bacterial growth, possibly by blocking dissociation of peptidyl tRNA from ribosomes, causing RNA-dependent protein synthesis to arrest. For treatment of staphylococcal and streptococcal infections. Age, weight, and severity of infection determine proper dosage in children. When bid dosing is desired, half the total daily dose may be taken q12h. For more severe infections, double the dose.
Adult Dose250 mg erythromycin stearate/base (or 400 mg ethylsuccinate) PO q6h 1 h ac, or 500 mg q12h
Alternatively, 333 mg PO q8h; increase to 4 g/d depending on severity of infection
Pediatric Dose30-50 mg/kg/d (15-25 mg/lb/d) PO divided q6-8h; double dose for severe infection
ContraindicationsDocumented hypersensitivity; hepatic impairment
InteractionsCoadministration may increase toxicity of theophylline, digoxin, carbamazepine, and cyclosporine; may potentiate anticoagulant effects of warfarin; coadministration with lovastatin and simvastatin increases risk of rhabdomyolysis
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsCaution in liver disease; estolate formulation may cause cholestatic jaundice; GI adverse effects are common (administer doses pc); discontinue use upon nausea, vomiting, malaise, abdominal colic, or fever

Drug NameMinocycline (Minocin)
DescriptionTreats infections caused by susceptible gram-negative and gram-positive organisms, in addition to infections caused by susceptible Chlamydia, Rickettsia, and Mycoplasma species.
Adult Dose100 mg PO bid for 5-7 d or longer for acne
Pediatric Dose<8 years: Not recommended
>8 years: 4 mg/kg PO initially, followed with 2 mg/kg q12h
ContraindicationsDocumented hypersensitivity; severe hepatic dysfunction
InteractionsBioavailability decreases with antacids that contain aluminum, calcium, magnesium, iron, or bismuth subsalicylate; can decrease effects of oral contraceptives, causing breakthrough bleeding and increased risk of pregnancy; tetracyclines can increase hypoprothrombinemic effects of anticoagulants
PregnancyD - Unsafe in pregnancy
PrecautionsPhotosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce dose in renal impairment; consider drug serum level determinations in prolonged therapy; tetracycline use during tooth development (second half of pregnancy through age 8 y) can cause permanent discoloration of teeth; Fanconilike syndrome may occur with outdated tetracyclines; hepatitis or lupuslike syndromes may occur

Drug NameClindamycin (Cleocin)
DescriptionLincosamide for treatment of serious skin and soft tissue staphylococcal infections. Also effective against aerobic and anaerobic streptococci (except enterococci). Inhibits bacterial growth, possibly by blocking dissociation of peptidyl tRNA from ribosomes, causing RNA-dependent protein synthesis to arrest.
Adult Dose75-300 mg PO bid/qid
Alternatively, 600 mg IV q8h
Pediatric DoseNot established; 20-40 mg/kg/d IV divided tid/qid suggested
ContraindicationsDocumented hypersensitivity; regional enteritis; ulcerative colitis; hepatic impairment; antibiotic-associated colitis
InteractionsIncreases duration of neuromuscular blockade induced by tubocurarine and pancuronium; erythromycin may antagonize effects of clindamycin; antidiarrheals may delay effect
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsAdjust dose in severe hepatic dysfunction; no adjustment necessary in renal insufficiency; associated with severe and possibly fatal colitis by allowing overgrowth of Clostridium difficile

Drug NameVancomycin (Vancocin, Vancoled, Lyphocin)
DescriptionPotent antibiotic directed against gram-positive organisms and active against Enterococcus species. Useful in the treatment of septicemia and skin structure infections. Indicated for patients who cannot receive, or who have failed to respond to, penicillins and cephalosporins or have infections with resistant staphylococci.
To avoid toxicity, current recommendation is to assay vancomycin trough levels after third dose drawn 0.5 h prior to next dosing. Use creatinine clearance to adjust dose in patients diagnosed with renal impairment.
Adult Dose1 g IV q12h (normal renal function)
Pediatric Dose40 mg/kg/d IV divided tid/qid for 7-10 d
ContraindicationsDocumented hypersensitivity
InteractionsErythema, histaminelike flushing, and anaphylactic reactions may occur when administered with anesthetic agents; when taken concurrently with aminoglycosides, risk of nephrotoxicity may increase above that with aminoglycoside monotherapy; effects in neuromuscular blockade may be enhanced when coadministered with nondepolarizing muscle relaxants
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCaution in renal failure, neutropenia; red man syndrome is caused by too rapid IV infusion (dose administered over a few min) but rarely happens when dose is administered IV over 2 h or as PO or IP administration; red man syndrome is not an allergic reaction

Drug NameTetracycline (Sumycin)
DescriptionInhibits bacterial protein synthesis by binding with 30S and, possibly, 50S ribosomal subunit(s). Tetracycline has anti-inflammatory activity.
Adult Dose250-500 mg PO q6h
Mild-to-moderate infections: 500 mg PO bid or 250 mg PO qid for 7-14 d
Pediatric Dose<8 years: Not recommended
>8 years: 25-50 mg/kg/d (10-20 mg/lb) PO qid
ContraindicationsDocumented hypersensitivity; severe hepatic dysfunction
InteractionsBioavailability decreases with antacids that contain aluminum, calcium, magnesium, iron, or bismuth subsalicylate; can decrease effects of oral contraceptives, causing breakthrough bleeding and increased risk of pregnancy; tetracyclines can increase hypoprothrombinemic effects of anticoagulants
PregnancyD - Unsafe in pregnancy
PrecautionsPhotosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce dose in renal impairment; consider drug serum level determinations in prolonged therapy; tetracycline use during tooth development (second half of pregnancy through age 8 y) can cause permanent discoloration of teeth; Fanconilike syndrome may occur with outdated tetracyclines

Drug Category: Antiandrogen therapies

These agents are reserved for patients with acne who have clinical signs of androgen excess and for those in whom other treatments have failed. Used in women with treatment-resistant, late-onset, or persistent acne. Some of these women have signs suggestive of hyperandrogenism (eg, hirsutism, irregular menses, menstrual dysfunction), but others are without abnormalities. Serum androgen levels may or may not be elevated.

Three options are available. Estrogen suppresses ovarian androgens (oral contraceptives), glucocorticoids suppress adrenal androgen, and antiandrogens (eg, spironolactone, cyproterone acetate) act at the peripheral level.

Drug NameSpironolactone (Aldactone)
DescriptionAldosterone antagonist inhibits ovarian and adrenal production of androgens. Competes with dihydrotestosterone, binding at hormone receptor sites on hair follicle cells. Also reduces 17-alpha-hydroxylase activity, lowering plasma levels of testosterone and androstenedione.
Adult Dose200 mg PO qd
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; anuria; renal failure; hyperkalemia
InteractionsMay decrease effect of anticoagulants; potassium and potassium-sparing diuretics may increase toxicity of spironolactone
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCategory D in pregnancy-induced hypertension; caution in renal and hepatic impairment

Drug NameCyproterone (Androcur)
DescriptionNot available in the United States. This is an oral contraceptive that is highly effective in improving acne. An androgen receptor antagonist and weak gonadal androgen production inhibitor. Also a weak progestin.
Adult Dose2 mg PO qd with either 0.035 or 0.050 mg ethynyl estradiol; clinical benefit can be enhanced by administering 50 or 100 mg PO qd from the 5th to the 14th day of cycle
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; pregnancy and breastfeeding; Dubin-Johnson syndrome; hepatic disease; blood-clotting disorder; Rotor syndrome
InteractionsNone reported
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCaution in chronic depression, diabetes with vascular changes, and sickle cell anemia

Drug Category: Oral retinoids

Isotretinoin is related to vitamin A and is very effective to control acne and to induce long-term remissions.

Drug NameIsotretinoin (Accutane)
DescriptionOral agent that treats serious dermatologic conditions. Synthetic 13-cis isomer of the naturally occurring tretinoin (trans-retinoic acid). Both agents are structurally related to vitamin A. Isotretinoin decreases sebaceous gland size and sebum production and may inhibit sebaceous gland differentiation and abnormal keratinization. Treatment is weight-based, and the standard course of treatment usually is from 16-20 wk.
Adult Dose0.5-1.5 mg/kg/d (usually 1 mg/kg/d) PO for 20 wk
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsToxicity may occur with vitamin A coadministration; pseudotumor cerebri or papilledema may occur when coadministered with tetracyclines; isotretinoin may reduce plasma levels of carbamazepine
PregnancyX - Contraindicated in pregnancy
PrecautionsSeverity of adverse effects proportional to daily dose; monitor triglyceride levels, LFTs, and CBC counts prior to and during treatment; if triglyceride levels >700-800 mg/dL, discontinue medication to diminish risk of pancreatitis; perform pregnancy test prior to commencing treatment; additional adverse effects include hyperostoses, cheilitis, headache, and amenorrhea

Drug Category: Acne products

These agents may modify or inhibit inflammatory process.

Drug NameAdapalene (Differin)
DescriptionModulates cellular differentiation, inflammation, and keratinization. May be tolerated by individuals who cannot tolerate tretinoin creams. A therapeutic response can be expected following 8-12 wk of therapy. Available as 0.1% gel or solution.
Adult DoseApply hs, some patients may tolerate bid dosing
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsNone Reported
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsAvoid contact with mucous membranes, eyes, mouth, and nostrils; avoid exposure to sunlight and sunlamps; dryness of skin, scaling, erythema, burning, and pruritus may occur

Drug NameErythromycin and benzoyl peroxide (Benzamycin)
DescriptionContains erythromycin, which is a macrolide antibiotic, as well as benzoyl peroxide. Benzoyl peroxide, in addition to being an antibacterial agent, is a keratolytic and desquamative agent. With benzoyl peroxide, free-radical oxygen is released upon administration, oxidizing bacterial proteins in sebaceous follicles and decreasing the number of anaerobic, bacterial, and irritating free fatty acids. Has keratolytic and comedolytic effects.
Erythromycin is indicated for infections caused by susceptible strains of microorganisms.
Adult DoseApply twice daily am and pm to affected areas after skin is washed thoroughly, rinsed with warm water, and gently patted dry
Pediatric Dose<12 years: Not established
>12 years: Administer as in adults
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsFor external use only; avoid contact with lips, eyelids, mucous membranes, and eyes; discontinue upon swelling, burning, or excessive dryness



Complications

  • Acne vulgaris: The prognosis of acne vulgaris usually is favorable, and the only sequela is scarring, which can be minimized. For patients with scarring, the options include superficial peeling, tissue augmentation with injected materials, and the use of deep abrasive therapy.
  • Other infections: These complications are described in the Clinical section.



Medical/Legal Pitfalls

  • Isotretinoin is contraindicated in pregnancy. A pregnancy test should be performed prior to commencing treatment, and patients should be warned about the drug's teratogenic effects.
  • Though frequently a nonpathogen, never automatically assume that the presence of Propionibacterium species in a sterile body fluid culture is due to contamination until a thorough history and physical examination and assessment is completed.



Media file 1:  Propionibacterium infection. Nodular-cystic acne.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 2:  Propionibacterium infection. Pustular acne.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo



  • Chaudhry R, Dhawan B, Pandey A, et al. Propionibacterium granulosum: a rare cause of endocarditis. J Infect. Nov 2000;41(3):284. [Medline].
  • Delyle LG, Vittecoq O, Bourdel A, et al. Chronic destructive oligoarthritis associated with Propionibacterium acnes in a female patient with acne vulgaris: septic-reactive arthritis?. Arthritis Rheum. Dec 2000;43(12):2843-7. [Medline].
  • Habif TP. Acne. In: Clinical Dermatology. St Louis, Mo: Mosby;. 1996.
  • Leyden JJ. Therapy for Acne Vulgaris. N Eng J Med. 1997;336:1156-1162.
  • Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. 6th ed. New York, NY: Churchill Livingstone;. 2005.
  • Webster G. Combination azelaic acid therapy for acne vulgaris. J Am Acad Dermatol. Aug 2000;43(2 Pt 3):S47-50. [Medline].

Propionibacterium Infections excerpt

Article Last Updated: Apr 27, 2006